- Home
- ADGM vs XAIR Comparison
ADGM vs XAIR Comparison
Compare ADGM & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADGM
- XAIR
- Stock Information
- Founded
- ADGM 2011
- XAIR 2011
- Country
- ADGM United States
- XAIR United States
- Employees
- ADGM N/A
- XAIR N/A
- Industry
- ADGM
- XAIR Medical/Dental Instruments
- Sector
- ADGM
- XAIR Health Care
- Exchange
- ADGM NYSE
- XAIR Nasdaq
- Market Cap
- ADGM 37.1M
- XAIR 34.7M
- IPO Year
- ADGM N/A
- XAIR N/A
- Fundamental
- Price
- ADGM $2.75
- XAIR $0.53
- Analyst Decision
- ADGM
- XAIR Strong Buy
- Analyst Count
- ADGM 0
- XAIR 4
- Target Price
- ADGM N/A
- XAIR $3.67
- AVG Volume (30 Days)
- ADGM 120.4K
- XAIR 633.8K
- Earning Date
- ADGM 11-19-2024
- XAIR 11-11-2024
- Dividend Yield
- ADGM N/A
- XAIR N/A
- EPS Growth
- ADGM N/A
- XAIR N/A
- EPS
- ADGM N/A
- XAIR N/A
- Revenue
- ADGM $399,000.00
- XAIR $2,342,000.00
- Revenue This Year
- ADGM N/A
- XAIR $640.47
- Revenue Next Year
- ADGM N/A
- XAIR $286.81
- P/E Ratio
- ADGM N/A
- XAIR N/A
- Revenue Growth
- ADGM 58.73
- XAIR 685.91
- 52 Week Low
- ADGM $2.33
- XAIR $0.30
- 52 Week High
- ADGM $9.34
- XAIR $2.36
- Technical
- Relative Strength Index (RSI)
- ADGM N/A
- XAIR 55.11
- Support Level
- ADGM N/A
- XAIR $0.42
- Resistance Level
- ADGM N/A
- XAIR $0.54
- Average True Range (ATR)
- ADGM 0.00
- XAIR 0.06
- MACD
- ADGM 0.00
- XAIR 0.00
- Stochastic Oscillator
- ADGM 0.00
- XAIR 48.85
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.